A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women

NCT07302035 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Vaginosis

Interventions

DRUG: GenSci142
DRUG: Placebo GenSci142

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]